1496. Bezlotoxumab Administered at the End of a Suppressive Drug Regimen for Patients with Multiply Recurrent Clostridioides difficile Infection
Tan, Xing, Danziger, Larry H, Gerding, Dale NVolume:
6
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz360.1360
Date:
October, 2019
File:
PDF, 267 KB
2019